Byrne Asset Management LLC Invests $658,000 in SPDR S&P Biotech ETF $XBI

Byrne Asset Management LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 5,399 shares of the exchange traded fund’s stock, valued at approximately $658,000.

A number of other large investors have also added to or reduced their stakes in the business. JPMorgan Chase & Co. grew its holdings in SPDR S&P Biotech ETF by 27.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after acquiring an additional 2,900,633 shares during the last quarter. Bessemer Group Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 9.3% during the third quarter. Bessemer Group Inc. now owns 1,632,988 shares of the exchange traded fund’s stock worth $163,624,000 after purchasing an additional 138,322 shares during the period. Ameriprise Financial Inc. grew its stake in shares of SPDR S&P Biotech ETF by 40.5% in the third quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock worth $122,906,000 after purchasing an additional 353,351 shares during the last quarter. Meitav Investment House Ltd. increased its holdings in SPDR S&P Biotech ETF by 70.3% in the third quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock valued at $68,156,000 after purchasing an additional 281,602 shares during the period. Finally, Greenhouse Funds LLLP increased its holdings in SPDR S&P Biotech ETF by 16.6% in the third quarter. Greenhouse Funds LLLP now owns 675,975 shares of the exchange traded fund’s stock valued at $67,733,000 after purchasing an additional 96,308 shares during the period.

SPDR S&P Biotech ETF Stock Up 3.7%

Shares of NYSEARCA:XBI opened at $123.92 on Thursday. The firm has a market cap of $8.28 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 12-month low of $66.66 and a 12-month high of $132.09. The business has a fifty day simple moving average of $125.18 and a 200 day simple moving average of $116.87.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.